TORONTO - Ontario Premier Doug Ford has denied a request from more than 20 mayors across the province to tweak instead of scrap the speed camera program, vowing to eliminate speeding through other ...

Absci (ABSI) will host a virtual seminar on December 11, 2025 at 10:00am ET focused on the company’s ABS-201 program for androgenetic alopecia. Additionally, Absci now expects to initiate the Phase ...

Toronto’s mayor is fighting to keep the city’s speed cameras in operation, with council passing a motion Wednesday it hopes will cause Premier Doug Ford to reconsider his pledge to get rid of them.

Toronto’s city council is offering up significant changes to its speed camera program, including scaling back the number of devices and restricting enforcement to daytime hours in school zones – in a ...

Ontario's premier responded to a letter from 22 municipal leaders Tuesday by saying he's not backing down on his plan to ban speed cameras, like this one in Toronto, across the province with ...

News headlines Ford Motor Company continues to face challenges with quality issues and recalls, despite recent earnings that exceeded expectations. The company is investing $370 million in its India ...

Engine: 5.0L V8 -inc: auto start-stop technology (STD) Transmission: Electronic 10-Speed Automatic -inc: SelectShift w/progressive range select and selectable drive modes: normal, ECO, sport, tow/haul ...

Ontario Premier Doug Ford has denied a request from more than 20 mayors across the province to tweak instead of scrap the speed camera program, vowing to eliminate speeding through other measures. The ...

Register for Ford Ice Center programming, complete on-ice waivers, view rink schedules and more using DaySmart Recreation on your phone, tablet or desktop. Click below to create your account or to ...

The $7,500 federal purchase tax credit for qualifying electric vehicles goes away after today, eliminated in President Donald Trump’s tax and spending bill passed on July 4.

Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadership Phase 1/2a trial now expected to begin in December 2025, ahead ...